All PlansAdministrativeLow impact
Recall: Quinapril-Hctz
UPMC Health Plan·Family Medicine, Internal Medicine, Cardiology +2 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Aurobindo Pharma USA Inc. has recalled two lots of quinapril and hydrochlorothiazide tablets due to cancer-causing nitrosamine impurity levels above acceptable limits. This is a drug safety recall that may affect patient prescriptions and medication dispensing.
Action Required
Immediately: Clinical staff should review patient medication lists to identify those taking recalled quinapril-HCTZ lots from Aurobindo Pharma. Contact affected patients for medication changes. Pharmacy team should remove recalled lots from inventory and coordinate alternative prescriptions with providers.